David F. Wiemer
Corporate Officer/Principal en University of Iowa .
Perfil
David F.
Wiemer is the founder of Terpenoid Therapeutics, Inc. which was founded in 2005.
He held the title of Director from 2012 to 2013.
Currently, he is a Professor at the University of Iowa.
Dr. Wiemer's education history includes an undergraduate degree from Marquette University and a doctorate from the University of Illinois.
Cargos activos de David F. Wiemer
| Empresas | Cargo | Inicio |
|---|---|---|
| University of Iowa | Corporate Officer/Principal | - |
Antiguos cargos conocidos de David F. Wiemer.
| Empresas | Cargo | Fin |
|---|---|---|
Terpenoid Therapeutics, Inc.
 Terpenoid Therapeutics, Inc. Medical DistributorsDistribution Services Terpenoid Therapeutics, Inc. operates as a biotechnology company focuses on anti-cancer therapeutics. The firm engages in creating, testing, and developing novel drug candidates using cutting-edge technologies. It is focused on discovering small molecule inhibitors of geranylgeranyl diphosphate synthase, a novel target with applicability towards cancer and other indication. The company was founded by Andrew J. Wiemer, Jeffery D. Neighbors, David F. Wiemer and Raymond J. Hohl in September 2005 and is headquartered in Coralville, IA. | Founder | - |
Formación de David F. Wiemer.
| Marquette University | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Terpenoid Therapeutics, Inc.
Terpenoid Therapeutics, Inc. Medical DistributorsDistribution Services Terpenoid Therapeutics, Inc. operates as a biotechnology company focuses on anti-cancer therapeutics. The firm engages in creating, testing, and developing novel drug candidates using cutting-edge technologies. It is focused on discovering small molecule inhibitors of geranylgeranyl diphosphate synthase, a novel target with applicability towards cancer and other indication. The company was founded by Andrew J. Wiemer, Jeffery D. Neighbors, David F. Wiemer and Raymond J. Hohl in September 2005 and is headquartered in Coralville, IA. | Distribution Services |
- Bolsa de valores
- Insiders
- David F. Wiemer
